This is the fourth installment of a five-part series titled “Diagnosis Overkill.” Genomic sequencing is playing a growing role in genetic sequencing for research and drug development. Today, patient testing is generally reserved for those who have already had a preliminary ...
Engagement is a Strategy, Not a Tool: Part 2, The Engagement Spectrum
The common refrain in health care circles is that most “people won't become engaged in care until it's too late.” But there are those who do get engaged with significant impact. What determines success? As behavioral scientist BJ Fogg says, start with “What behavior do we want ...